Publications by authors named "Chengxiang Lian"

Claim this Profile
C
Clinical characteristics of Netherton syndrome and exploration of targeted biologic therapy: two case reports.
Wanyan Xiang, Chengxiang Lian, Jiarong Lu, Wenjun Zheng, Qiuju Li

Front Allergy· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing the ChatGPT aptitude: A competent and effective Dermatology doctor?
Chengxiang Lian, Xin Yuan, Santosh Chokkakula, Guanqing Wang, Biao Song, Chengliang Yin

Heliyon· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Colchicine Alleviates Rosacea by Inhibiting Neutrophil Inflammation Activated by the TLR2 Pathway.
Xin Yuan, Liang Sheng, Guang Shi, Leiwei Jiang, Chengxiang Lian

Inflammation· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A nomogram for predicting survival in patients with skin non-keratinizing large cell squamous cell carcinoma: A study based on the Surveillance, Epidemiology, and End Results database.
Jinrong Zhang, Wei Yang, Chengxiang Lian, Qiqi Zhao, Wai-Kit Ming

Front Med (Lausanne)· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RJT-101, a novel camptothecin derivative, is highly effective in the treatment of melanoma through DNA damage by targeting topoisomerase 1.
Chengxiang Lian, Shousong Cao, Weiqi Zeng, Yuliang Li, Juan Su

Biochem Pharmacol· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Titration of cell-associated varicella-zoster virus with the MV9G reporter cell line for antiviral studies.
Xiaojie Li, Xiaoxia Li, Wei Gong, Guanqing Wang, Zhenling Lu, Chengxiang Lian

J Virol Methods· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting CD147 is a Novel Strategy for Antitumor Therapy.
ChengXiang Lian, Yeye Guo, Jianglin Zhang, Xiang Chen, Cong Peng

Curr Pharm Des· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis